Evidence map›Paper›PMID 40177444›Full record

ArticleCureus2025

A Rare Case of Endometrial Adenosarcoma and Its Management: A Case Report and Literature Review.

Shereen Rafiq, Sofia Ali, Hend Makky Abouzied, Yusra Qamar

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shereen RafiqRadiology, Faisalabad Medical University, Faisalabad, PAK.
Sofia AliMedicine, Peninsula Medical School, Plymouth, GBR.
Hend Makky AbouziedMedicine, Thumbay University Hospital, Ajman, ARE.
Yusra QamarObstetrics and Gynecology, King George's Medical University, Lucknow, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometrial adenosarcoma is a rare and aggressive uterine malignancy composed of both epithelial and stromal components, most commonly affecting postmenopausal women. This case report describes the diagnosis of endometrial adenosarcoma in a 52-year-old woman who presented with abnormal vaginal bleeding. A hysterectomy was performed, and a histopathological examination confirmed the diagnosis. Due to the high risk of recurrence, the patient underwent surgical resection followed by adjuvant chemotherapy. Given the rarity of this tumor, its management presents a significant clinical challenge. This case underscores the diagnostic approach, therapeutic strategies, and the critical role of close follow-up in managing endometrial adenosarcoma.

Indexed as

chemotherapydiagnosisendometrial adenosarcomahysterectomymanagementuterine malignancy

Identifiers

PMID40177444
PMCPMC11964285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.